Next Science Ltd (AU:NXS) has released an update.
Next Science Ltd has restructured its sales force to cut costs and improve efficiency, projecting savings of approximately US$6 million annually. With a reported increase in product sales and a robust gross margin, the company is confident in achieving its FY24 revenue guidance of US$36m-$40m and anticipates being EBITDA and cashflow positive in the second half of the fiscal year. This strategic shift includes transitioning to a flexible, commission-based sales team and capitalizing on new market opportunities to drive future growth.
For further insights into AU:NXS stock, check out TipRanks’ Stock Analysis page.
